Drug intelligence / Profile preview

Restaxil

Development stage
Unknown
Lead developer
PharmaSGP
Administration
Oral, Topical
01

Overview

Restaxil is a natural, over-the-counter (OTC) homeopathic medicine developed and marketed by PharmaSGP for the treatment of neuralgic (nerve) pain. It is available in two primary formulations: an oral liquid (drops) and a topical gel (Restaxil Nervenschmerzgel). The liquid formulation contains a complex of five homeopathic active ingredients: *Gelsemium sempervirens* (D2), *Spigelia anthelmia* (D2), *Iris versicolor* (D2), *Cyclamen purpurascens* (D3), and *Cimicifuga racemosa* (D2). The gel formulation utilizes a dual complex of *Iris versicolor* (D2) and *Spigelia anthelmia* (D2). As a homeopathic product, it operates on the principle of high dilution and does not have a defined conventional pharmacological mechanism of action or specific biological target. It is indicated for various forms of nerve pain, including sciatica, radiating back pain, and pain associated with shingles or fibromyalgia. Restaxil is primarily marketed in Germany and Austria, where it is a leading brand in the systemic chemical-free OTC pain relief market.

Brand names
RestaxilRestaxil Nervenschmerzgel

Beyond the preview

Go deeper on Restaxil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restaxil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call